PMDA Medical Safety Information No. 73: Use of Insulin Syringes
PMDA医療安全情報No.73「インスリン専用注射器の使用について 投与量の誤りが重大な健康被害につながるおそれがあります」を掲載しました
Published: 2026-04-27 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Low · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
On 2026-04-27, the Pharmaceuticals and Medical Devices Agency (PMDA) announced the publication of Medical Safety Information No. 73 on the use of insulin syringes. The announcement warns that dosing errors could lead to serious harm to health.
Business Impact
Healthcare professionals and patients using insulin syringes may be affected because the notice highlights the potential for serious harm from dosing errors.
Recommended Action
Review of the official PMDA notice could clarify the dosing-error scenarios and precautions described for insulin syringe use.